{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:50:01Z","timestamp":1792457401066,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57144-7","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:43:04Z","timestamp":1781170984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proof-of-concept study: longitudinal immune biomarker signatures in treatment-na\u00efve IgG4-related disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Marta","family":"Lopez-Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Moya-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Franco","family":"Leyva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar Concepci\u00f3n","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Codes-Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Calvet","family":"Lacruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Magallares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Castellv\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Barros-Membrilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngels","family":"Santaolalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e8ctor","family":"Corominas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"6","key":"57144_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone, J. H., Zen, Y. & Deshpande, V. IgG4-related disease. N. Engl. J. Med. 366(6), 539\u2013551. https:\/\/doi.org\/10.1056\/NEJMra1104650 (2012).","journal-title":"N. Engl. J. Med."},{"issue":"9976","key":"57144_CR2","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa, T., Zen, Y., Pillai, S. & Stone, J. H. IgG4-related disease. Lancet 385(9976), 1460\u20131471. https:\/\/doi.org\/10.1016\/S0140-6736(14)60720-0 (2015).","journal-title":"Lancet"},{"issue":"1","key":"57144_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10165-011-0508-6","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara, H. et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod. Rheumatol. 22(1), 1\u201314. https:\/\/doi.org\/10.1007\/s10165-011-0508-6 (2012).","journal-title":"Mod. Rheumatol."},{"key":"57144_CR4","doi-asserted-by":"publisher","unstructured":"Zhang, Y. O., Iwasaki, T., Kawaguchi, T., Takahashi, H., Kawaguchi, S., Kanno, A., et al; Japanese IgG4-Related Disease Working Consortium. IgG4-related disease in the Japanese population: A whole-genome sequencing study. Lancet Rheumatol. 8(1), e11\u2013e22 (2026). https:\/\/doi.org\/10.1016\/S2665-9913(25)00195-X.","DOI":"10.1016\/S2665-9913(25)00195-X"},{"issue":"22","key":"57144_CR5","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.3390\/diagnostics14222583","volume":"14","author":"M Lopez-Gomez","year":"2024","unstructured":"Lopez-Gomez, M. et al. Comparative analysis of classification criteria in IgG4-related disease and evaluating diagnostic accuracy from a retrospective cohort in clinical practice. Diagnostics (Basel) 14(22), 2583. https:\/\/doi.org\/10.3390\/diagnostics14222583 (2024).","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"57144_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers, M. N., Khosroshahi, A., Augustin, T., Deshpande, V. & Stone, J. H. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann. Rheum. Dis. 74(1), 14\u201318. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204907 (2015).","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"57144_CR7","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.3390\/ijms26115325","volume":"26","author":"M Arias-Intriago","year":"2025","unstructured":"Arias-Intriago, M. et al. IgG4-Related Disease: current and future insights into pathological diagnosis. Int. J. Mol. Sci. 26(11), 5325. https:\/\/doi.org\/10.3390\/ijms26115325 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"57144_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/cells14090639","volume":"14","author":"LL Shi","year":"2025","unstructured":"Shi, L. L. et al. Role of IgG4 antibodies in human health and disease. Cells 14(9), 639. https:\/\/doi.org\/10.3390\/cells14090639 (2025).","journal-title":"Cells"},{"issue":"2","key":"57144_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10266-018-0377-y","volume":"107","author":"T Maehara","year":"2019","unstructured":"Maehara, T., Moriyama, M. & Nakamura, S. Pathogenesis of IgG4-related disease: a critical review. Odontology 107(2), 127\u2013132. https:\/\/doi.org\/10.1007\/s10266-018-0377-y (2019).","journal-title":"Odontology"},{"key":"57144_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100047","volume":"3","author":"C Liu","year":"2020","unstructured":"Liu, C., Zhang, P. & Zhang, W. Immunological mechanism of IgG4-related disease. J. Transl. Autoimmun. 3, 100047. https:\/\/doi.org\/10.1016\/j.jtauto.2020.100047 (2020).","journal-title":"J. Transl. Autoimmun."},{"key":"57144_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.imlet.2019.01.008","volume":"207","author":"F Ito","year":"2019","unstructured":"Ito, F. et al. IL-10+ T follicular regulatory cells are associated with the pathogenesis of IgG4-related disease. Immunol. Lett. 207, 56\u201363. https:\/\/doi.org\/10.1016\/j.imlet.2019.01.008 (2019).","journal-title":"Immunol. Lett."},{"issue":"3","key":"57144_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","volume":"134","author":"H Mattoo","year":"2014","unstructured":"Mattoo, H. et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J. Allergy Clin. Immunol. 134(3), 679\u2013687. https:\/\/doi.org\/10.1016\/j.jaci.2014.03.034 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"57144_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace, Z. S. et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann. Rheum. Dis. 74(1), 190\u2013195. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205233 (2015).","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"57144_CR14","first-page":"159","volume":"37 Suppl 118","author":"M Lanzillotta","year":"2019","unstructured":"Lanzillotta, M. et al. Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease. Clin. Exp. Rheumatol. 37 Suppl 118(3), 159\u2013166 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"57144_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13075-018-1718-5","volume":"20","author":"M Lanzillotta","year":"2018","unstructured":"Lanzillotta, M. et al. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse. Arthritis Res. Ther. 20(1), 222. https:\/\/doi.org\/10.1186\/s13075-018-1718-5 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"57144_CR16","doi-asserted-by":"publisher","first-page":"651357","DOI":"10.3389\/fimmu.2021.651357","volume":"12","author":"M Akiyama","year":"2021","unstructured":"Akiyama, M. et al. Peripheral TIGIT+ T follicular helper cells that produce high levels of interleukin-21 via OX40 represent disease activity in IgG4-related disease. Front. Immunol. 12, 651357. https:\/\/doi.org\/10.3389\/fimmu.2021.651357 (2021).","journal-title":"Front. Immunol."},{"issue":"9","key":"57144_CR17","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1136\/annrheumdis-2017-212110","volume":"77","author":"M Akiyama","year":"2018","unstructured":"Akiyama, M., Yasuoka, H., Yoshimoto, K. & Takeuchi, T. CC-chemokine ligand 18 is a useful biomarker associated with disease activity in IgG4-related disease. Ann. Rheum. Dis. 77(9), 1386\u20131387. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212110 (2018).","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"57144_CR18","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1093\/rheumatology\/keab344","volume":"60","author":"G Mancuso","year":"2021","unstructured":"Mancuso, G. et al. Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease. Rheumatology (Oxford) 60(8), 3947\u20133949. https:\/\/doi.org\/10.1093\/rheumatology\/keab344 (2021).","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"57144_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1474-4422(17)30471-4","volume":"17","author":"MA AbdelRazek","year":"2018","unstructured":"AbdelRazek, M. A., Venna, N. & Stone, J. H. IgG4-related disease of the central and peripheral nervous systems. Lancet Neurol. 17(2), 183\u2013192. https:\/\/doi.org\/10.1016\/S1474-4422(17)30471-4 (2018).","journal-title":"Lancet Neurol."},{"issue":"7","key":"57144_CR20","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1016\/S2665-9913(24)00022-5","volume":"6","author":"G Katz","year":"2024","unstructured":"Katz, G. et al. Proliferative features of IgG4-related disease. Lancet Rheumatol. 6(7), e481\u2013e492. https:\/\/doi.org\/10.1016\/S2665-9913(24)00022-5 (2024).","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"57144_CR21","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1038\/s41598-024-53206-w","volume":"14","author":"DC Onwuka","year":"2024","unstructured":"Onwuka, D. C. et al. Mass spectrometry in IgG4-related disease diagnosis. Sci. Rep. 14(1), 2584. https:\/\/doi.org\/10.1038\/s41598-024-53206-w (2024).","journal-title":"Sci. Rep."},{"issue":"2","key":"57144_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/medicina62020323","volume":"62","author":"P Moya-Alvarado","year":"2026","unstructured":"Moya-Alvarado, P. et al. Immunological biomarkers to assess activity and treatment response in IgG4-related disease. Medicina (Kaunas) 62(2), 323. https:\/\/doi.org\/10.3390\/medicina62020323 (2026).","journal-title":"Medicina (Kaunas)"},{"issue":"12","key":"57144_CR23","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00380-018-1203-8","volume":"33","author":"S Kasashima","year":"2018","unstructured":"Kasashima, S. et al. Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases. Heart Vessels 33(12), 1471\u20131481. https:\/\/doi.org\/10.1007\/s00380-018-1203-8 (2018).","journal-title":"Heart Vessels"},{"key":"57144_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/259408","author":"MN Carruthers","year":"2012","unstructured":"Carruthers, M. N., Stone, J. H., Deshpande, V. & Khosroshahi, A. Development of an IgG4-RD responder index. Int. J. Rheumatol. https:\/\/doi.org\/10.1155\/2012\/259408 (2012).","journal-title":"Int. J. Rheumatol."},{"key":"57144_CR25","doi-asserted-by":"publisher","unstructured":"Peng, L., Li, J., Zhou, J., Fei, Y., Dong, L., Liu, Y. Y., et al.; Chinese IgG4-RD Consortium. The development and initial validation of IgG4-related disease damage index: a consensus report from Chinese IgG4-RD Consortium. RMD Open 10(1):e003938. https:\/\/doi.org\/10.1136\/rmdopen-2023-003938 (2024).","DOI":"10.1136\/rmdopen-2023-003938"},{"issue":"9","key":"57144_CR26","first-page":"2025","volume":"41","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Characterizing IgG4-related disease with ^18F-FDG PET\/CT. Eur. J. Nucl. Med. Mol. Imaging 41(9), 2025\u20132034 (2014).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"57144_CR27","first-page":"574","volume":"36","author":"Z Bai","year":"2022","unstructured":"Bai, Z. et al. Clinical value of ^18F-FDG PET\/CT in IgG4-related disease. Ann. Nucl. Med. 36(6), 574\u2013584 (2022).","journal-title":"Ann. Nucl. Med."},{"key":"57144_CR28","doi-asserted-by":"publisher","unstructured":"Wallace, Z. S., Naden, R. P., Chari, S., Choi, H., Della-Torre, E., Dicaire, J. F., et al; American College of Rheumatology\/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-Related Disease. Arthritis Rheumatol. 72(1), 7\u201319. https:\/\/doi.org\/10.1002\/art.41120 (2020).","DOI":"10.1002\/art.41120"},{"key":"57144_CR29","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","volume":"78","author":"ZS Wallace","year":"2019","unstructured":"Wallace, Z. S. et al. Clinical phenotypes of IgG4-related disease: An analysis of two international cross-sectional cohorts. Ann. Rheum. Dis. 78, 406\u2013412 (2019).","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"57144_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/intimm\/dxp112","volume":"22","author":"R Spolski","year":"2010","unstructured":"Spolski, R. & Leonard, W. J. IL-21 and T follicular helper cells. Int. Immunol. 22(1), 7\u201312. https:\/\/doi.org\/10.1093\/intimm\/dxp112 (2010).","journal-title":"Int. Immunol."},{"key":"57144_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13075-016-1064-4","volume":"18","author":"M Akiyama","year":"2016","unstructured":"Akiyama, M. et al. Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease. Arthritis Res. Ther. 18, 167. https:\/\/doi.org\/10.1186\/s13075-016-1064-4 (2016).","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"57144_CR32","first-page":"186","volume":"36 Suppl 112","author":"T Sasaki","year":"2018","unstructured":"Sasaki, T. et al. Risk factors of relapse following glucocorticoid tapering in IgG4-related disease. Clin. Exp. Rheumatol. 36 Suppl 112(3), 186\u2013189 (2018).","journal-title":"Clin. Exp. Rheumatol."},{"key":"57144_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/14397595.2019.1650694","volume":"30","author":"H Tsuboi","year":"2020","unstructured":"Tsuboi, H. et al. Pathogenesis of IgG4-related disease: comparison with Sj\u00f6gren\u2019s syndrome. Mod. Rheumatol. 30, 7\u201316 (2020).","journal-title":"Mod. Rheumatol."},{"issue":"3","key":"57144_CR34","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s10067-023-06861-9","volume":"43","author":"J Joseph","year":"2024","unstructured":"Joseph, J. et al. Myofibroblast and pro-fibrotic cytokines in fibrosis of IgG4-related disease (IgG4-RD) patients from South Asia: preliminary data. Clin. Rheumatol. 43(3), 1103\u20131110. https:\/\/doi.org\/10.1007\/s10067-023-06861-9 (2024).","journal-title":"Clin. Rheumatol."},{"key":"57144_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825386","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Clinical characteristics and CD4+ T cell subsets in IgG4-related disease. Front Immunol. 13, 825386. https:\/\/doi.org\/10.3389\/fimmu.2022.825386 (2022).","journal-title":"Front Immunol."},{"issue":"2","key":"57144_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/annrheumdis-2016-209139","volume":"76","author":"T Maehara","year":"2017","unstructured":"Maehara, T. et al. Lesional CD4+ IFN-\u03b3+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis. Ann. Rheum. Dis. 76(2), 377\u2013385. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209139 (2017).","journal-title":"Ann. Rheum. Dis."},{"issue":"4\u20135","key":"57144_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.autrev.2014.01.034","volume":"13","author":"E Della Torre","year":"2014","unstructured":"Della Torre, E., Lanzillotta, M. & Doglioni, C. B-cell and T-cell interactions in IgG4-related disease. Autoimmun. Rev. 13(4\u20135), 424\u2013428. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.034 (2014).","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"57144_CR38","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2016.02.004","volume":"138","author":"H Mattoo","year":"2016","unstructured":"Mattoo, H. et al. Clonal expansion of CD4+ cytotoxic T lymphocytes in IgG4-related disease. J. Allergy Clin. Immunol. 138(3), 825\u2013838. https:\/\/doi.org\/10.1016\/j.jaci.2016.02.004 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"57144_CR39","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.3390\/diagnostics11122355","volume":"11","author":"O Gheysens","year":"2021","unstructured":"Gheysens, O., Jamar, F., Glaudemans, A. W. J. M., Yildiz, H. & van der Geest, K. S. M. Semi-quantitative and quantitative [18F]FDG-PET\/CT indices for diagnosing large vessel vasculitis: A critical review. Diagnostics 11(12), 2355. https:\/\/doi.org\/10.3390\/diagnostics11122355 (2021).","journal-title":"Diagnostics"},{"issue":"5","key":"57144_CR40","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.55563\/clinexprheumatol\/l7se2n","volume":"40","author":"B Ming","year":"2022","unstructured":"Ming, B., Zhong, J. & Dong, L. Role of eosinophilia in IgG4-related disease. Clin. Exp. Rheumatol. 40(5), 1038\u20131044. https:\/\/doi.org\/10.55563\/clinexprheumatol\/l7se2n (2022).","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57144-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57144-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57144-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:36:17Z","timestamp":1787614577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57144-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57144"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57144-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain (protocol code IIBSP-EIG-2022-92, date 1 August 2022). Given the prospective design, all cases were anonymized.","order":2,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26601"}}